92 Koketsu et al.
REFERENCES
4-Methyl-2-piperidino-5-propyl-1,3-selenazole 3j
1
Orange liquid. IR (neat): 2933, 2855, 1535 cm−1; H
[1] (a) Katritzky, A. R.; Rees, C. W.; Scriven, E. F. V.
Comprehensive Heterocyclic Chemistry II; Pergamon
Press: New York, 1996; Vols. 1–11; (b) Back, T. G.
Organoselenium Chemistry: A Practical Approach;
Oxford University Press: New York, 1999; (c) Wirth, T.
Organoselenium Chemistry. Modern Developments
in Organic Synthesis; Springer: New York, 2000; (d)
Murai, T.; Kato, S. Top Curr Chem 2000, 208, 177; (e)
Ishihara, H.; Koketsu, M.; Fukuta, Y.; Nada, F. J Am
Chem Soc 2001, 123, 8408.
NMR (500 MHz, CDCl3): δ 0.95 (3H, t, J = 7.5 Hz,
CH3), 1.54–1.68 (8H, m, CH2), 2.10 (3H, s, CH3), 2.59
(2H, t, J = 7.5 Hz, CH2), 3.34–3.36 (4H, m, CH2); 13
C
NMR (125 MHz, CDCl3): δ 13.5, 15.5, 24.2, 25.2, 26.0,
30.4, 50.4, 125.3 (1 J (77Se–13C) = 92.4 Hz), 143.9,
170.2; 77Se NMR (95 MHz, CDCl3): δ 561.5; MS (CI):
m/z = 273 [M+ + 1].
[2] (a) Koketsu, M.; Ishihara, H.; Wu, W.; Murakami, K.;
Saiki, I. Eur J Pharm Sci 1999, 9, 157; (b) Wu, W.;
Murakami, K.; Koketsu, M.; Yamada, Y.; Saiki, I. Anti-
cancer Res 1999, 19, 5375; (c) Cho, S. I.; Koketsu, M.;
Ishihara, H.; Matsushita, M.; Nairn, A. C.; Fukazawa,
H.; Uehara, Y. Biochim Biophys Acta 2000, 1475, 207;
(d) Koketsu, M.; Yang, H. O.; Kim, Y. M.; Ichihashi,
M.; Ishihara, H. Org Lett 2001, 3, 1705; (e) Koketsu,
M.; Choi, S. Y.; Ishihara, H.; Lim, B. O.; Kim, H.; Kim,
S. Y. Chem Pharm Bull 2002, 50, 1594; (f) Gutzkow,
K. B.; La˚hne, H. U.; Naderi, S.; Torgersen, K. M.;
Ska˚lhegg, B.; Koketsu, M.; Uehara, Y.; Blomhoff,
H. K. Cell Signal 2003, 15, 871; (g) Park, Y.-J.;
Koketsu, M.; Kim, J. M.; Yeo, J.-H.; Ishihara, H.; Lee,
K.-G.; Kim, S. Y.; Kim, C.-K. Biol Pharm Bull 2003,
26, 1657.
4-(2-Methylpropyl)-2-piperidino-1,3-selenazole
3k
1
Orange liquid. IR (neat): 2937, 2864, 1534 cm−1; H
NMR (500 MHz, CDCl3): δ 0.91 (6H, d, J = 6.9 Hz,
CH3), 1.62–1.67 (6H, m, CH2), 1.96–2.07 (1H, m, CH),
2.36 (2H, d, J = 7.5 Hz, CH2), 3.39–3.41 (4H, m, CH2),
6.56 (1H, s, CH) (2 J (77Se–1H) = 52.1 Hz); 13C NMR
(125 MHz, CDCl3): δ 22.5, 24.3, 25.2, 27.7, 42.5, 50.7,
104.3 (1 J (77Se–13C) = 93.6 Hz), 154.3, 173.4; 77Se
NMR (95 MHz, CDCl3): δ 542.6; MS (CI): m/z = 273
[M+ + 1].
[3] (a) Takahashi, M.; Watanabe, S.; Kasai, T. Heterocy-
cles 1980, 14, 1921; (b) Kristian, P.; Koscik, D.; Gonda,
J. Collect Czech Chem Commun 1983, 48, 3567; (c)
Maslankiewicz, A.; Skrzypek, L.; Niedbala, A. Pol J
Chem 1996, 70, 54; (d) Keil, D.; Hartmann, H. Phos-
phorus Sulfur Silicon Relat Elem 1999, 152, 169; (e)
Shafiee, A.; Ebrahimzadeh, M. A.; Maleki, A. J Hete-
rocycl Chem 1999, 36, 901; (f) Koketsu, M.; Suzuki,
N.; Ishihara, H. J Org Chem 1999, 64, 6473; (g) Zhou,
Y.; Linden, A.; Heimgartner, H. Helv Chim Acta 2000,
83, 1576; (h) Attanasi, O. A.; Filippone, P.; Guidi, B.;
Perrulli, F. R.; Santeusanio, S. Synlett 2001, 144.
[4] Keil, D.; Hartmann, H. Phosphorus Sulfur Silicon
Relat Elem 1999, 152, 169.
4-Methyl-5-(2-methylethyl)-2-piperidino-1,3-
selenazole 3l
Yellow solid. mp: 38.0–40.0◦C; IR (KBr): 2934, 2853,
1541 cm−1; 1H NMR (500 MHz, CDCl3): δ 1.20 (6H, d,
J = 6.9 Hz, CH3), 1.59–1.67 (6H, m, CH2), 2.12 (3H, s,
CH3), 3.00–3.07 (1H, m, J = 6.9 Hz, CH), 3.37 (4H, t,
J = 5.2 Hz CH2); 13C NMR (125 MHz, CDCl3): δ 15.7,
24.3, 25.3, 26.1, 29.2, 50.4, 134.3, 142.0, 170.0; 77Se
NMR (95 MHz, CDCl3): δ 528.9; MS (CI): m/z = 273
[M+ + 1].
[5] (a) Keil, D.; Hartmann. H. Dyes and Pigments 2000,
44, 149; (b) Keil, D.; Hartmann. H.; Zug, I.; Schroder,
A. J Prakt Chem 2000, 42, 169.
[6] (a) Geisler, K.; Ku¨ nzler, A.; Below, H.; Bulka, E.;
Pfeiffer, W.-D.; Langer, P. Synthesis 2004, 97;
(b) Geisler, K.; Pfeiffer, W.-D.; Ku¨ nzler, A.; Below, H.;
Bulka, E.; Langer, P. Synthesis 2004, 875.
[7] (a) King, L. C.; Hlavacek, R. J. J Am Chem Soc 1951,
73, 1864; (b) Moriarty, R. M.; Vaid, B. K.; Duncan,
M. P.; Levy, S. G.; Prakash, O.; Goyal, S. Synthesis
1992, 845; (c) Zhang, P.-F.; Chen, Z.-C. Synthesis 2000,
1219.
4-Methoxy-4-methyl-5-methylene-2-piperidino-
4,5-dihydro-1,3-selenazole 4
1H NMR (500 MHz, CDCl3): δ 1.60–1.68 (6H, m,
CH2), 2.17 (3H, s, CH3), 3.33 (3H, s, CH3), 3.38–3.43
(4H, m, CH2), 3.00–3.07 (1H, m, J = 6.9 Hz, CH),
4.46 (2H, S, CH2); 13C NMR (125 MHz, CDCl3): δ
15.7, 24.1, 25.1, 50.4, 56.9, 67.9, 120.22 (1 J (77Se–
13C) = 91.2 Hz), 147.6, 171.9; 77Se NMR (95 MHz,
CDCl3): δ 564.5; MS (CI): m/z = 274 [M+ + 1].
[8] (a) Koketsu, M.; Fukuta, Y.; Ishihara, H.; Tetrahedron
Lett 2001, 42, 6333; (b) Koketsu, M.; Takakura, N.;
Ishihara, H. Synth Commun 2002, 32, 3075.